We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

117 hedge funds and large institutions have $229M invested in C4 Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

852% more call options, than puts

Call options by funds: $200K | Put options by funds: $21K

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

27% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 33

3% more funds holding

Funds holding: 114 → 117 (+3)

2.22% less ownership

Funds ownership: 82.31% → 80.09% (-2.2%)

35% less capital invested

Capital invested by funds: $353M → $229M (-$124M)

Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
42
Reduced
33
Closed
13
Calls
$200K
Puts
$21K
Net Calls
+$179K
Net Calls Change
-$42K

Top Buyers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
+$8.29M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$5.89M
3
State Street
State Street
Massachusetts
+$4.03M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.93M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.07M

Top Sellers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$11.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.45M
3
PA
Perceptive Advisors
New York
-$6.72M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$4.8M
5
DCM
Driehaus Capital Management
Illinois
-$2.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
76
Aquatic Capital Management
Illinois
$80K +$114K +13,800 New
Legal & General Group
77
Legal & General Group
United Kingdom
$79.3K +$8.89K +1,072 +9%
American Century Companies
78
American Century Companies
Missouri
$70.7K +$99.4K +11,986 New
Rockefeller Capital Management
79
Rockefeller Capital Management
New York
$69K – – –
Corient Private Wealth
80
Corient Private Wealth
Florida
$67.1K +$94.4K +11,380 New
Principal Financial Group
81
Principal Financial Group
Iowa
$67.1K +$94.2K +11,365 New
SEI Investments
82
SEI Investments
Pennsylvania
$66.3K -$3.04K -366 -3%
Federated Hermes
83
Federated Hermes
Pennsylvania
$65.3K +$83.5K +10,076 +1,013%
CC
84
Corton Capital
Ontario, Canada
$62.1K +$87.3K +10,526 New
EAM
85
Erste Asset Management
Austria
$61.6K – – –
OQS
86
Occudo Quantitative Strategies
Florida
$61.2K -$179K -21,623 -68%
Teacher Retirement System of Texas
87
Teacher Retirement System of Texas
Texas
$61K -$7.22K -871 -8%
SW
88
SVB Wealth
Massachusetts
$59K – – –
HSBC Holdings
89
HSBC Holdings
United Kingdom
$58.9K +$84.2K +10,155 New
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$49K +$59.9K +7,229 +684%
SO
91
STRS Ohio
Ohio
$33K – – –
QT
92
Quantbot Technologies
New York
$30K +$42.2K +5,093 New
AB
93
Amalgamated Bank
New York
$30K – – –
Lazard Asset Management
94
Lazard Asset Management
New York
$27K – – –
Amundi
95
Amundi
France
$25.7K – – –
AIP
96
Ameritas Investment Partners
Nebraska
$24.4K – – –
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
$20.2K – – –
Nisa Investment Advisors
98
Nisa Investment Advisors
Missouri
$18K – – –
Northwestern Mutual Wealth Management
99
Northwestern Mutual Wealth Management
Wisconsin
$15.5K – – –
MLICM
100
Metropolitan Life Insurance Company (MetLife)
New York
$15.2K – – –
2 3
4
5 6

CCCC Hedge Fund Activity: Q4 2022 in Review

117 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q4 2022, worth a combined $229M — down 35% from $353M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CCCC positions and 13 closed out — a net gain of 4 holders — while 42 added to existing stakes and 33 trimmed.

The largest buyer was Soleus Capital Management, adding an estimated $8.29M. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $11.4M sold.

  • 117 institutional investors held C4 Therapeutics (CCCC) as of Q4 2022, up from 114 in Q3 2022.
  • Funds reported $229M of C4 Therapeutics stock for Q4 2022, down 35% quarter-over-quarter.
  • 17 funds opened new C4 Therapeutics positions in Q4 2022 and 13 closed out, a net change of +4 holders.
  • The largest C4 Therapeutics buyer in Q4 2022 was Soleus Capital Management, an estimated $8.29M added.
  • The largest C4 Therapeutics seller in Q4 2022 was Pictet Asset Management (Switzerland), an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2022.